FDA Approves Alpharma's KADIAN(R) New 200 Mg Strength

FDA Approves Alpharma's KADIAN(R) New 200 Mg Strength
KADIAN(R) is Alpharma's branded extended release morphine sulfate product and is currently marketed in 20 mg, 30 mg, 50 mg, 60 mg, 80 mg and 100 mg dosages. The added dosage strength is intended to assist in physicians' efforts to individualize their patient's treatments by offering more choices in managing their pain.